Oksimetazolin
|
|
(IUPAC) ime
|
3-(4,5-dihidro-1H-imidazol-2-ilmetil)- 2,4-dimetil-6-tert-setil-fenol
|
Klinički podaci
|
Robne marke
|
Afrin, Ocuclear, Drixine
|
AHFS/Drugs.com
|
Monografija
|
Identifikatori
|
CAS broj
|
1491-59-4
|
ATC kod
|
R01AA05 R01AB07, S01GA04
|
PubChem[1][2]
|
4636
|
DrugBank
|
DB00935
|
ChemSpider[3]
|
4475
|
UNII
|
8VLN5B44ZY Y
|
KEGG[4]
|
D08322 Y
|
ChEMBL[5]
|
CHEMBL762 Y
|
Hemijski podaci
|
Formula
|
C16H24N2O
|
Mol. masa
|
260,375 g·mol−1
|
SMILES
|
eMolekuli & PubHem
|
InChI |
InChI=1S/C16H24N2O/c1-10-8-13(16(3,4)5)15(19)11(2)12(10)9-14-17-6-7-18-14/h8,19H,6-7,9H2,1-5H3,(H,17,18) Y Key: WYWIFABBXFUGLM-UHFFFAOYSA-N Y |
|
Fizički podaci
|
Tačka topljenja
|
301.5 °C (575 °F)
|
Farmakokinetički podaci
|
Poluvreme eliminacije
|
5-6 sata
|
Farmakoinformacioni podaci
|
Trudnoća
|
?
|
Pravni status
|
GSL (UK) OTC (SAD)
|
Oksimetazolin je topikalni dekongestiv. On je adrenomimetik koji selektivno agonizuje α1 i parcijalno α2 adrenergičke receptore.[6] On se koristi u obliku oksimetazolin hidrohlorida u proizvodima kao što su Afrin, Dristan, Nasivin, Logicin, Vicks Sineks, Visin L.R., Sudafed OM, i Zicam. Ovaj lek je razvijen iz ksilometazolina 1961.[7] Oksimetazolin je dostupan kao nazalni sprej.
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
- ↑ Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.
- ↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
- ↑ Westfall Thomas C, Westfall David P, "Chapter 6. Neurotransmission: The Autonomic and Somatic Motor Nervous Systems" (Chapter). Brunton LL, Lazo JS, Parker KL: Goodman & Gilman's The Pharmacological Basis of Therapeutics, 11e: http://www.accessmedicine.com/content.aspx?aID=954433.
- ↑ German Patent 1,117,588